Technical Analysis for BCAB - BioAtla, Inc.

Grade Last Price % Change Price Change
grade D 45.38 -2.45% -1.14
BCAB closed down 2.45 percent on Friday, January 15, 2021, on 43 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical BCAB trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Stochastic Sell Signal Bearish -2.45%
New 52 Week Closing High Bullish -2.45%
Pocket Pivot Bullish Swing Setup -2.45%
New 52 Week High Strength -2.45%
Up 3 Days in a Row Strength -2.45%
Up 4 Days in a Row Strength -2.45%
Older End-of-Day Signals for BCAB ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 10 hours ago
Down 2 % about 10 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Down 1% about 10 hours ago
Up 2% about 11 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of various cancers. Its lead product candidate is BA3011, a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for soft tissue and bone sarcoma tumors, non-small cell lung cancer (NSCLC), and other tumor types. It also develops BA3021, a CAB ADC for NSCLC and Melanoma; and BA3071, which is a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for renal cell carcinoma, NSCLC, small cell lung cancer, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. The company was founded in 2007 and is based in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Clinical Medicine Drugs Cancers Monoclonal Antibodies Cancer Immunotherapy Health Care Small Cell Lung Cancer Tumor Non Small Cell Lung Cancer Melanoma Targeted Therapy Bladder Cancer Hepatocellular Carcinoma Renal Cell Carcinoma Cervical Cancer Nsclc Adc Gastric Cancer Non Small Cell Lung Carcinoma

Is BCAB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 49.49
52 Week Low 27.15
Average Volume 285,078
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 36.67
10-Day Moving Average 39.65
Average True Range 3.70
ADX 0.0
+DI 39.11
-DI 3.56
Chandelier Exit (Long, 3 ATRs ) 38.39
Chandelier Exit (Short, 3 ATRs ) 38.25
Upper Bollinger Band 45.63
Lower Bollinger Band 27.72
Percent B (%b) 0.99
BandWidth 48.84
MACD Line 3.74
MACD Signal Line 1.95
MACD Histogram 1.7869
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 49.73
Resistance 3 (R3) 50.08 48.98 49.00
Resistance 2 (R2) 48.98 47.87 48.80 48.76
Resistance 1 (R1) 47.18 47.19 46.63 46.83 48.52
Pivot Point 46.08 46.08 45.80 45.90 46.08
Support 1 (S1) 44.28 44.97 43.73 43.93 42.24
Support 2 (S2) 43.18 44.29 43.01 42.00
Support 3 (S3) 41.38 43.18 41.76
Support 4 (S4) 41.03